U.S., June 9 -- ClinicalTrials.gov registry received information related to the study (NCT07631338) titled 'Low-grade Gliomas in Argentina: Incidence, Survival, and Therapeutic Strategies' on June 01.
Brief Summary: Low-grade gliomas (LGG) are slow-growing primary brain tumors (WHO grades I-II), and their incidence, survival, and treatment patterns in middle-income settings such as Argentina remain poorly characterized. This retrospective, multicenter study comprises two complementary cohorts:
1. Cohort 1: The "captive" population covered under the Hospital Italiano de Buenos Aires Health Plan (January 2011-December 2023) to estimate LGG incidence density.
2. Cohort 2: Histologically confirmed LGG patients treated at the major referral c...